Restructure of the Office of New Drugs (OND) - REdI 2020

FDA shares information about the reorganized Office of New Drugs, its new offices, divisions and current leadership.
Presenter:
Judit Milstein Chief
Project Management Staff
Division of Regulatory Operations for Specialty Medicine
Office of Regulatory Operations (ORO) | OND
Center for Drug Evaluation and Research (CDER)
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2020 Playlist: • 2020 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: [e-mail]
Phone: [phone] I [phone]